top of page

BIO-Europe 2026: Abalos Therapeutics will have p1 data on its lead project in 1H27, a non-oncolytic arenavirus-based product that is being tested in refractory/relapsed solid tumors

1 hour ago
1 min read

CEO Gerben Moolhuizen tells us how the company has developed an arena-virus based platform that allows for systemic delivery, and a more targeted approach than other virus-based immunotherapies.




Coverage brought to you by



Join the BiotechTV mailing list

Thanks for subscribing!

Follow BiotechTV

  • Twitter
  • LinkedIn
  • Facebook
  • TikTok
  • Instagram

Also look for unique social pages for BiotechTV U.

Sponsor Spotlight

Mispro_Logo_2023_Primary-4.png

Mispro is an AAALAC-accredited contract vivarium organization (CVO) offering a network of full-service vivarium rental lab facilities for preclinical in vivo rodent studies. Along with access to state-of-the-art lab spaces, Mispro supports its clients with comprehensive laboratory animal research services, including husbandry, veterinary, technical, and regulatory compliance oversight. With locations in all major U.S. biotech hubs, Mispro is committed to helping biosciences companies of all sizes and therapeutic indications achieve their research goals.

bottom of page